Pear Therapeutics receives FDA Breaktrough Device Designation
Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announ…
Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announ…
In the IASP 2021 Virtual World Congress of Pain, the results from Orion Corporation’s pilot study ‘VIRPI’ were announced. The novel treatment, a digit…
The hybrid session, held in partnership with Plexus Ventures and Healthware Group and focused on digital therapeutics (DTx) endorsement by pharma comp…
We are glad to resume our conversation with Henrik Matthies, Managing Director of health innovation hub (hih), who was our guest at Digital Health Glo…
Originally aimed at Italy, the new international edition of the book curated by a panel of Digital Therapeutics experts covers the global DTx landscap…
Paige, the global leader in AI-based diagnostic software in pathology, today announced that the U.S. Food and Drug Administration (FDA) has granted de…
Freespira, Inc., the maker of the first FDA-cleared digital therapeutic to significantly reduce or eliminate symptoms of panic attacks, panic disorder…
Twelve-month evaluation shows the value of incorporating Big Health’s Sleepio, a clinically-based digital therapeutic for insomnia, into a psychologic…
The Start-up Discovery sessions at Frontiers Health Global Conference are designed with the aim to offer visibility both to emerging and est…
Akili Interactive, a leading prescription digital therapeutics company and maker of EndeavorRx®, the first and only prescription video game treat…